The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term survival and clinical efficacy in patients with advanced pancreatic and small bowel metastatic neuroendocrine tumors (GEP-NET) after I.V. 90Y DOTATATE.
Wojciech Rogowski
No relevant relationships to disclose
Ewa Wachula
No relevant relationships to disclose
Jolanta Zok
No relevant relationships to disclose
Anna Lewczuk
No relevant relationships to disclose
Jaroslaw Cwikla
No relevant relationships to disclose
Piotr Wysocki
No relevant relationships to disclose